The 2026 US Talent Report: Benchmarking America’s STEM Pipeline Amid the Great Talent Competition | Stanford HAI
AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034 as AI Reshapes Patient Recruitment, Data Analysis and Drug Development, says Maximize Market Research
This is a paid press release. Contact the press release distributor directly with any inquiries.
PR Newswire
11 min read
PUNE, India, Sept. 25, 2026 /PRNewswire/ — The Global AI in Clinical Trials Market was valued at USD 2 Billion in 2025 and is projected to grow at a 15.5% CAGR from 2026 to 2034, reaching USD 7.32 Billion by 2034, according to Maximize Market Research.
Global AI in Clinical Trials Market
The Global AI in Clinical Trials Market Report 2026 provides a detailed assessment of market trends, clinical research activity, AI adoption, patient recruitment, data analysis, safety monitoring, drug discovery, personalized medicine, trial-phase applications, end-user demand, competitive developments, and market forecasts through 2034. The market is segmented by Trial Phase, Technology, Application, End-Users, and Region, covering Phase I, Phase II, and Phase III trials; machine learning, natural language processing, and deep learning; and applications including patient recruitment, data analysis, safety monitoring, drug discovery, and personalized medicine.
The market is expanding as pharmaceutical and biotechnology companies increasingly use AI to improve the speed and efficiency of clinical research. AI tools are being applied to patient screening, cohort selection, trial design, large-scale data analysis, safety evaluation, and treatment optimization. By analyzing complex patient datasets, AI can help researchers identify suitable trial participants, detect patterns more quickly, and support more targeted clinical decision-making.
Growing use of machine learning, deep learning, AI-driven patient monitoring, real-world evidence, decentralized trials, and AI-enabled drug discovery is creating new opportunities across the clinical research ecosystem. Pharmaceutical companies, CROs, hospitals, and research institutes are adopting AI to streamline workflows, improve patient recruitment, strengthen data quality, and reduce delays in drug development. These developments are expected to support the AI in Clinical Trials Market as it grows from USD 2 Billion in 2025 to USD 7.32 Billion by 2034 at a CAGR of 15.5%.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.maximizemarketresearch.com/request-sample/222597/
Global AI in Clinical Trials Market gains momentum as pharmaceutical companies, CROs, and research institutions turn to AI for faster patient recruitment, smarter data analysis, improved safety monitoring, personalized medicine, and more efficient drug development, says Maximize Market Research.
Global AI in Clinical Trials Market Size & Forecast
Related Posts
